(Q40665340)

22 September 2017

Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients (English)

1 reference

22 September 2017

1 reference

Kenneth V. I. Rolston

3

object named as

K Rolston

1 reference

22 September 2017

G Bodey

1

1 reference

22 September 2017

D Abi-Said

2

1 reference

22 September 2017

I Raad

4

1 reference

22 September 2017

E Whimbey

5

1 reference

22 September 2017

1 August 1996

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

22 September 2017

1 reference

22 September 2017

15

1 reference

22 September 2017

8

1 reference

22 September 2017

625-634

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01691147

22 September 2017

0 references

cites work

A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FBF01691147

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691147

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691147

Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691147

CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological Characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691147

Therapy with cefoperazone plus sulbactam against disseminated infection due to cefoperazone-resistant Pseudomonas aeruginosa and Escherichia coli in granulocytopenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691147

Disposition of radiolabeled imipenem and cilastatin in normal human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691147

Septicemia and Shock Syndrome Due to Viridans Streptococci: A Case-Control Study of Predisposing Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691147

The changing epidemiology of infections at cancer hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691147

Resistance to vancomycin and teicoplanin: an emerging clinical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691147

Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691147

Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01691147

Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients

21 January 2018

1 reference

12 December 2020

An open trial of cefoperazone plus sulbactam for the treatment of fever in cancer patients

1 reference

12 December 2020

A Comparison of Imipenem to Ceftazidime With or Without Amikacin as Empiric Therapy in Febrile Neutropenic Patients

1 reference

12 December 2020

Candidiasis in cancer patients

1 reference

12 December 2020

A Randomized Comparative Trial of Three Aminoglycosides—Comparison of Continuous Infusions of Gentamicin, Aaikacin and Sisomicin Combined with Carbenicillin in the Treatment of Infections in Neutropenic Patients with Malignancies

1 reference

12 December 2020

Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes.

1 reference

12 December 2020

Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses

1 reference

12 December 2020

Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients

1 reference

12 December 2020

Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients

1 reference

12 December 2020

USE OF GAMMA GLOBULIN INFECTION IN ACUTE-LEUKEMIA PATIENTS

1 reference

12 December 2020

Efficacy of sulbactam/cefoperazone for the treatment of infections in patients with hematologic diseases

1 reference

12 December 2020

In vitro assessment of sulbactam plus cefoperazone in the treatment of bacteria isolated from cancer patients.

1 reference

12 December 2020

Candida sepsis: pathogenesis and principles of treatments

1 reference

12 December 2020

Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem

1 reference

12 December 2020

A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections.

1 reference

12 December 2020

Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans

1 reference

12 December 2020

Effect of a single dose of cefotaxime or ceftriaxone on human faecal flora. A double-blind study

1 reference

12 December 2020

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

12 December 2020

Imipenem/cilastatin therapy of infections in cancer patients

1 reference

12 December 2020

Granulocytopenia and cancer therapy. Past problems, current solutions, future challenges

1 reference

12 December 2020

Infection and transfusion therapy in acute leukaemia

1 reference

12 December 2020

Therapy of infection in patients with granulocytopenia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01691147

1 reference

Dimensions Publication ID

22 September 2017

0 references

1 reference